Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Portkey Partners with Aporia to Bring Secure and Reliable AI Guardrails to Production
-
Harvia closes ThermaSol acquisition
-
Total voting rights and Capital
-
HotelPlanner Partners with EventR for Hotel Integration
-
Rail Vision Successfully Installed its AI- based Product at a Leading Global Mining Company
-
LPL Financial Welcomes Englert Financial
-
Emergent BioSolutions Completes Sale of RSDL® (Reactive Skin Decontamination Lotion) Kit to SERB Pharmaceuticals for $75 Million
-
Myriad Genetics Appoints Jennifer Fox as Chief Legal Officer
-
2024-2025 CN Grain Plan Builds on Strong Performance
-
DriveItAway Holdings, Inc. Partners with Chapman Automotive Group in Philadelphia to Supply New Vehicles and To Provide Its Micro-Lease to Ownership Program to Chapman Store Customers
-
DriveItAway Holdings, Inc. Partners with Chapman Automotive Group in Philadelphia to Supply New Vehicles and To Provide Its Micro-Lease to Ownership Program to Chapman Store Customers
-
ORYZON reports financial results and corporate update for half-year ending June 30, 2024
-
Global Water Resources Declares Monthly Dividend
-
Form 8.3 - Keywords Studios Plc
-
SELLAS Life Sciences Announces $21.0 Million Registered Direct Offering Priced at a Premium to Market
-
CEMATRIX To Report Second Quarter Results On August 7, 2024
-
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2024 Financial Results on August 6, 2024
-
EMCORE Corporation to Host Fiscal 2024 Third Quarter Conference Call on August 7, 2024
-
Sow Good to Hold Second Quarter 2024 Conference Call on Thursday, August 15, 2024 at 10:00 a.m. ET
-
Adial Pharmaceuticals Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044
-
Neuronetics to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Barfresh Expands Annual Production Capacity by Additional 50 million Units with New Third Party Location with Ability for Further Future Expansion
-
Celularity Reports Full Year 2023 Combined Net Sales of $22.8 Million, a 26.7% Increase Over Full Year 2022, and Announces First Half 2024 Expected Combined Net Sales of $26.9 Million Representing 290
-
Global Food Manufacturer Adopts SaverOne System for Supply Chain Truck Protection
-
Alarum to Participate in the Canaccord Genuity 44th Annual Global Growth Conference
-
Global Mofy CEO Invited by NVIDIA China to Engage with Industry Leaders at SIGGRAPH 2024
-
Repeat: Treatment.com AI announces AI Pharmacy Assistant
-
Allogene Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update
-
GigaCloud Technology Inc to Announce Second Quarter and First Half 2024 Financial Results on August 6, 2024
-
RenovoRx Announces Publication of Positive Early-Stage Clinical Data in International Peer-Reviewed Journal, The Oncologist®
-
TuneIn Partners with India Today Group To Bring News Programming to the World
-
Safe Harbor Financial to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
-
Grizzly Industrial Selects Bridgeline’s HawkSearch
-
Vimeo Announces AI-Powered Video Translation with Authentic Voice Cloning
-
Janover’s New Insurtech Platform, Achieves Profitability in Second Month of Operation; Increases Recurring Revenue by More Than 60% for the Month of May
-
AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024
-
Form 8.3 - Balanced Commercial Property Trust Limited
-
Diana Shipping Inc. Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2024; Declares Cash Dividend of $0.075 Per Common Share for the Second Quarter 2024
-
Diana Shipping Inc. Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2024; Declares Cash Dividend of $0.075 Per Common Share for the Second Quarter 2024
-
Form 8.3 - Equals Group PLC
-
Theriva™ Biologics Receives Rare Pediatric Drug Designation by the U.S. FDA for VCN-01 for the Treatment of Retinoblastoma
-
CIP Real Estate Acquires Silicon Valley’s Tully Business Center for $40 million
-
Freddie Mac Announces Second Quarter 2024 Financial Results
-
Athira Pharma Presents Preclinical Data Demonstrating New Insights into the Mechanism by Which Fosgonimeton Protects Neurons from Alzheimer’s Disease-Related Pathology at the Alzheimer’s Associati
-
Arcadia Earns Certified Data Partner Designation in NCQA Data Aggregator Validation Program
-
Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion
-
Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.
-
Spectral AI Announces Continuing Progress in Development of Handheld DeepView SnapShot M® for Military Field Use
-
Ironwall CEO Calls for Diligent Protection of Employees’ Personal Data in Wake of Recent Healthcare Organization Cyberattacks
-
Olaplex Holdings, Inc. Announces Participation in the Canaccord Genuity 44th Annual Growth Conference on August 14th
